Veru Inc. (NASDAQ:VERU) traded at $3.43 at last check on Monday, Jun 29, making an upward move of 6.85% on its previous day’s price.
Looking at the stock we see that its previous close was $3.21 and the beta (5Y monthly) reads 0.4 with the day’s price range being $3.2900 – 3.7886. In terms of its 52-week price range, VERU has a high of $4.74 and a low of $1.67. The company’s stock has gained about -8.04% over that past 30 days.
On the other hand, looking at the outlook for the VERU stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 50% Buy.
Based on estimates by 4 analysts where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, none have rated the Veru Inc. (VERU) stock as a Hold, while 4 rate it as a Buy. None analysts rate it as outperform while none of them rated it as underperform, whereas none suggests the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the VERU stock currently stands at 0, and the current price level is 0.76% off its SMA20 and -2.25% from its 50-day simple moving average. The RSI (14) is pointing at 51.08 while the volatility over the past week is 1073% and drops to 7.64% over the past one month. The beta value is 0.4, while the average true range (ATR) is currently pointing at 0.28. The average price target for the stock over the next 12 months is $8.5, with the estimates having a low of $6 and a high of $13. These price ends are 74.93% and +279.01% off the current price level respectively, although investors could be excited at the prospect of a +118.66% if the VERU share price touches on the median price of $7.5.
Let’s briefly compare Veru (VERU) stock to its peers. We find that today’s price change of +6.85% and +61.03% over the past 12 months for VERU betters that of Abbott Laboratories (ABT), which has seen its stock price rise 0.34% in the latest trading session and is +5.84% over the last one year. Another of its peers Medtronic Inc (MDT) has climbed 1.68% today, but is -7.32% down over the past year, while Stryker Corp (SYK) is also up 6.85% yet its price remains in the green at 61.03% over the same period. Abbott has a P/E ratio of 44.66 compared to Veru’s 0 and Medtronic’s 25.63. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 2.32% and 1.47%, respectively, in early deals.
Coming back to Veru Inc. (NASDAQ:VERU), we note that the average 3-month trading volume was 559.48 Million, while that of the preceding 10-day period stands at 1.83 Million. Current shares outstanding are 66.1 Million.
According to data from Thomson Reuters, insiders hold 24.77% of the company’s shares while institutions hold 13.93%. The data shows that short shares as of June 14, 2020, stood at 304.8 Million at a short ratio of 0.72. This represents a 0.46% Short interest in Shares outstanding on June 14, 2020. Shares short rose in June from the previous month at 213.71 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock +2.39% up in year-to-date price movement.